Reduced duration of cytopenias following melphalan conditioning and autografting for multiple myeloma. [electronic resource]
- Blood Jun 2002
- 4251-2; author reply 4252 p. digital
Publication Type: Comment; Letter
0006-4971
10.1182/blood-2002-02-0624 doi
Combined Modality Therapy Hematopoietic Stem Cell Transplantation--adverse effects Humans Melphalan--therapeutic use Multiple Myeloma--drug therapy Neutropenia--prevention & control Thrombocytopenia--prevention & control Transplantation, Autologous Whole-Body Irradiation